Cargando…
Evaluation of Side Effects and Long-Term Protection of a Sustained-Release Injectable Moxidectin Formulation against Dirofilaria immitis Infection in Dogs: An Observational—In Field Multicentric Study
SIMPLE SUMMARY: The sustained-release moxidectin formulation of Afilaria SR is labelled to prevent Dirofilaria immitis infection in dogs for a period of six months. An observational—in field multicentric study was design to evaluate the tolerability and the long-term prevention of Afilaria SR in Ita...
Autores principales: | Vercelli, Cristina, Bertolotti, Luigi, Gelsi, Elisa, Gazza, Carlo, Re, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415797/ https://www.ncbi.nlm.nih.gov/pubmed/36006323 http://dx.doi.org/10.3390/vetsci9080408 |
Ejemplares similares
-
Efficacy of oral, topical and extended-release injectable formulations of moxidectin combined with doxycycline in Dirofilaria immitis naturally infected dogs
por: Ciuca, Lavinia, et al.
Publicado: (2023) -
Use of Slow-Release Injectable Moxidectin for Treatment of Dirofilaria immitis Infection During Pregnancy
por: Alberigi, Bruno, et al.
Publicado: (2020) -
ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
por: McTier, Tom L., et al.
Publicado: (2019) -
Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs
por: McTier, Tom L., et al.
Publicado: (2017) -
Efficacy of semi-annual therapy of an extended-release injectable moxidectin suspension and oral doxycycline in Dirofilaria immitis naturally infected dogs
por: Alberigi, Bruno, et al.
Publicado: (2020)